Opens in a new tab

Global Regulatory Partners Joins the Association of Japan Industrialists Club – Tokyo

Announcement

Tokyo, Japan — October 29, 2025 — GLOBAL REGULATORY PARTNERS GK (“GRP”) is pleased to announce that it has officially become a member of the Association of Japan Industrialists Club – Tokyo (東京産業人クラブ, Tokyo Sangyojin Club) and its Women’s Division as of October 28, 2025. 

GRP is honored to be accepted into the Association of Japan Industrialists Club – Tokyo, which has traditionally been composed of Japan’s domestic enterprises. Through this membership, GRP will actively contribute to the Club’s initiatives by sharing its global expertise in healthcare business management, leadership and market access. 

“This membership represents a meaningful milestone for GRP,” said Dr. Suzan Davis, President and CEO of GRP. “It reinforces our long-term commitment to supporting Japan’s healthcare industry and Japanese patients by fostering international collaboration, knowledge exchange and expertise in bridging innovation and access” 

APPRECIATION AND TRIBUTE TO THE LATE MS. YAEKO SAGAWA 

GRP extends its heartfelt gratitude to the late Ms. Yaeko Sagawa, President of Sakura Golf Corporation, and Deputy Chairperson of the Tokyo Industrialists Club. Her encouragement and endorsement were instrumental in GRP’s acceptance into the Club and its Women’s Division. Ms. Sagawa’s dedication to empowering women entrepreneurs continues to inspire future generations. GRP honors her legacy with deep respect and appreciation. 

ABOUT THE TOKYO INDUSTRIALISTS CLUB 

Founded in 1955, the Tokyo Industrialists Club unites leaders from Japan’s manufacturing and business sectors to promote innovation, collaboration, and sustainable growth. With over 70 years of history, the Club supports small and medium-sized enterprises (SMEs) through lectures, study groups, factory tours, and international exchanges. Its Women’s Division fosters leadership among women executives and provides a unique forum for professional and personal development. 

ABOUT GLOBAL REGULATORY PARTNERS 

Global Regulatory Partners (GRP) is a leading provider of regulatory affairs, clinical, compliance, and market access solutions for the pharmaceutical, biotechnology, and medical device industries entering Japan.   

By acting as a Market Authorization Holder (MAH) in Japan, GRP enables its partners to enter Japanese market faster and accelerate Japanese patients access to innovative healthcare products they need. 

For PDF Version of Full Article, please check below link:

GRP-Association of Japan Industrialists Club_Press_Release_Final-sd

Related News

  • GLOBAL REGULATORY PARTNERS JAPAN JOINS THE TOKYO CHAMBER OF COMMERCE AND INDUSTRY (TCCI)

    Global Regulatory Partners Japan (GRP Japan) is pleased to announce that it has joined the Tokyo Chamber of Commerce and Industry (TCCI / 東京商工会議所), effective October 2026. GRP Japan will belong to the Minato Branch (港支部), one of TCCI’s 23 ward-based branches, strengthening the company’s connection with the local business community in Minato Ward.
    View More

  • Global Regulatory Partners Announces MHLW Approval of Aflibercept Biosimilar Prefilled Syringe in Japan

    Tokyo, Japan - October 26, 2026 - Global Regulatory Partners GK (GRP) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) granted marketing approval on October 13, 2026 for Aflibercept BS Solution for Intravitreal Injection Kit 40 mg/mL [GRP] (prefilled syringe (PFS) presentation), a biosimilar to EYLEA®¹ (aflibercept), for ophthalmic use.
    View More

  • Baqsimi® Nasal Powder Featured in the September 2026 Issue of Nikkei DI

    Global Regulatory Partners GK (GRP Japan) is pleased to share that Baqsimi® Nasal Powder, for which GRP Japan serves as the Marketing Authorization Holder (MAH) in Japan, is featured in the September 2026 issue of Nikkei Drug Information (Nikkei DI). Nikkei DI is a professional publication for pharmacists and other healthcare professionals in Japan, providing information on pharmaceuticals, clinical practice, medication management and developments relevant to pharmacy practice.
    View More

  • GRP JAPAN JOINS THE JAPAN RADIOPHARMACEUTICALS ASSOCIATION

    Tokyo, Japan — October 2026 — Global Regulatory Partners Japan (GRP Japan) is pleased to announce that it has joined the Japan Radiopharmaceuticals Association, effective October 2026. The membership marks an important step in GRP Japan’s continued expansion into the radiopharmaceutical and nuclear medicine sector, complementing the company’s established capabilities in pharmaceuticals, biologics, medical devices, and diagnostics. As a Marketing Authorization Holder (MAH) and local regulatory partner for international healthcare companies entering Japan, GRP Japan is expanding its capabilities to support the specialized regulatory, quality, importation, supply-chain, and lifecycle requirements associated with radiopharmaceutical products. Through its membership, GRP Japan looks forward to industry collaboration and to contributing its regulatory and market-access experience to the continued development of the sector in Japan.
    View More